Zero-dimensional carbon nanomaterials for central nervous system diseases

Nascimento, Tyciane de Souza; Benjamin, Stephen Rathinaraj; Assis, Albert Layo Costa de; Bezerra, Jessica Rabelo; Gomes, Jessica Maria Pessoa; Andrade, Geanne Matos de; Oriá, Reinaldo B.

doi:10.1088/978-0-7503-4048-9ch9

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Numerous nanoparticles with broad surface areas improve loading capacity and reactant mass transfer for high analytical sensitivity [32]. Recent years have seen an increase in the manufacturing of these biosensors, connected to the widespread utilization of nanomaterials such as graphene, its compounds, and nanocomposites (e.g., graphene oxides (GO) and CNT) [33,34].…”

Section: Electrochemical Biosensorsmentioning

confidence: 99%

“…Neurotransmitters are significant biological substances implicated in numerous nervous system disorders (NSDs). ePADs are capable of detecting neurotransmitters from very small sample sizes, allowing for quick and accurate diagnosis of neurotransmitter-related diseases [34]. Furthermore, these ePADs are highly sensitive and able to detect even trace amounts of neurotransmitters, making them an invaluable tool for preclinical studies.…”

Section: Point-of-care Epads For Neurotransmitter Monitoringmentioning

confidence: 99%

See 1 more Smart Citation

Advancement in Paper-Based Electrochemical Biosensing and Emerging Diagnostic Methods

et al. 2023

View full text Add to dashboard Cite

The utilization of electrochemical detection techniques in paper-based analytical devices (PADs) has revolutionized point-of-care (POC) testing, enabling the precise and discerning measurement of a diverse array of (bio)chemical analytes. The application of electrochemical sensing and paper as a suitable substrate for point-of-care testing platforms has led to the emergence of electrochemical paper-based analytical devices (ePADs). The inherent advantages of these modified paper-based analytical devices have gained significant recognition in the POC field. In response, electrochemical biosensors assembled from paper-based materials have shown great promise for enhancing sensitivity and improving their range of use. In addition, paper-based platforms have numerous advantageous characteristics, including the self-sufficient conveyance of liquids, reduced resistance, minimal fabrication cost, and environmental friendliness. This study seeks to provide a concise summary of the present state and uses of ePADs with insightful commentary on their practicality in the field. Future developments in ePADs biosensors include developing novel paper-based systems, improving system performance with a novel biocatalyst, and combining the biosensor system with other cutting-edge tools such as machine learning and 3D printing.

show abstract

Section: Electrochemical Biosensorsmentioning

confidence: 99%

Section: Point-of-care Epads For Neurotransmitter Monitoringmentioning

confidence: 99%